1. Lipid Association of India (LAI) expert consensus statement on management of dyslipidaemia in Indians 2017: part 2.
- Author
-
Iyengar, S. S., Puri, R., Narasingan, S. N., Nair, D. R., Mehta, V., Mohan, J. C., Wangnoo, S. K., Dalal, J. J., Jha, V., Puri, S., Misra, A., Daga, M. K., Varma, M., Jasuja, S., Upadhyaya, S., Kasliwal, R. R., Bansal, M., Mehrotra, R., Jain, A., and Talwar, K. K.
- Subjects
DYSLIPIDEMIA ,KIDNEY diseases ,HEART failure ,IMMUNODEFICIENCY ,JOINT diseases - Abstract
These Lipid Association of India (LAI) recommendations refer to specific patient populations. They follow the previously published LAI part 1 recommendations. These part 2 LAI recommendations focus on specific patient groups. These include patients with heart failure, chronic kidney disease, non-alcoholic fatty liver disease, cerebrovascular disease, thyroid disorders, inflammatory joint diseases, familial hypercholesterolaemia and human immunodeficiency virus infection. We also consider women, the elderly and post-transplantation patients. The current recommendations are based, as much as possible, on available data from Indian populations. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF